Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Diclofenac Sodium Plaster EQI7 vs Flector
NCT04585321Phase 1Completed
- Sponsor
- Fidia Farmaceutici
- Start
- Nov 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of diclofenac in acute pain (2 arms), sponsored by Fidia Farmaceutici. Primary endpoints: Average Steady State Maximum Plasma Concentration and Area Under the Curve over Dosing Interval. Started Nov 2017; status: completed.
02
Drugs
diclofenac
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04585321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04585321.